Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma.

Literature DB >> 32923855

Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma.

Angela Steineck¹, Niklas Krumm², Jay F Sarthy^1,3, Colin C Pritchard², Teresa Chapman², Andrew W Stacey², Nicholas A Vitanza^1,3, Bonnie Cole^1,4.

Abstract

Entities: Chemical Disease Species

Year: 2019 PMID： 32923855 PMCID： PMC7446378 DOI： 10.1200/PO.19.00028

Source DB: PubMed Journal: JCO Precis Oncol ISSN： 2473-4284

× No keyword cloud information.

26 in total

1. Immunity to homologous grafted skin; the relationship between the antigens of blood and skin.

Authors: P B MEDAWAR
Journal: Br J Exp Pathol Date: 1946-02

Review 2. Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature.

Authors: Teresa Deinlein; Sigurd F Lax; Thomas Schwarz; Roberta Giuffrida; Karin Schmid-Zalaudek; Iris Zalaudek
Journal: Eur J Cancer Date: 2017-07-19 Impact factor: 9.162

3. Microsatellite instability detection by next generation sequencing.

Authors: Stephen J Salipante; Sheena M Scroggins; Heather L Hampel; Emily H Turner; Colin C Pritchard
Journal: Clin Chem Date: 2014-06-30 Impact factor: 8.327

4. Efficacy of anti-programmed cell death-1 immunotherapy for skin carcinomas and melanoma metastases in a patient with xeroderma pigmentosum.

Authors: G Salomon; A Maza; S Boulinguez; C Paul; L Lamant; E Tournier; J Mazereeuw-Hautier; N Meyer
Journal: Br J Dermatol Date: 2018-02-26 Impact factor: 9.302

5. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.

Authors: Naiyer A Rizvi; Matthew D Hellmann; Alexandra Snyder; Pia Kvistborg; Vladimir Makarov; Jonathan J Havel; William Lee; Jianda Yuan; Phillip Wong; Teresa S Ho; Martin L Miller; Natasha Rekhtman; Andre L Moreira; Fawzia Ibrahim; Cameron Bruggeman; Billel Gasmi; Roberta Zappasodi; Yuka Maeda; Chris Sander; Edward B Garon; Taha Merghoub; Jedd D Wolchok; Ton N Schumacher; Timothy A Chan
Journal: Science Date: 2015-03-12 Impact factor: 47.728

6. Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.

Authors: Colin C Pritchard; Stephen J Salipante; Karen Koehler; Christina Smith; Sheena Scroggins; Brent Wood; David Wu; Ming K Lee; Suzanne Dintzis; Andrew Adey; Yajuan Liu; Keith D Eaton; Renato Martins; Kari Stricker; Kim A Margolin; Noah Hoffman; Jane E Churpek; Jonathan F Tait; Mary-Claire King; Tom Walsh
Journal: J Mol Diagn Date: 2013-11-02 Impact factor: 5.568

Review 7. Functional characterization of global genomic DNA repair and its implications for cancer.

Authors: Philip C Hanawalt; James M Ford; Daniel R Lloyd
Journal: Mutat Res Date: 2003-11 Impact factor: 2.433

8. The life in sight application study (LISA): design of a randomized controlled trial to assess the role of an assisted structured reflection on life events and ultimate life goals to improve quality of life of cancer patients.

Authors: Renske Kruizinga; Michael Scherer-Rath; Johannes B A M Schilderman; Mirjam A G Sprangers; Hanneke W M Van Laarhoven
Journal: BMC Cancer Date: 2013-07-26 Impact factor: 4.430

9. Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.

Authors: Laura Q M Chow; Robert Haddad; Shilpa Gupta; Amit Mahipal; Ranee Mehra; Makoto Tahara; Raanan Berger; Joseph Paul Eder; Barbara Burtness; Se-Hoon Lee; Bhumsuk Keam; Hyunseok Kang; Kei Muro; Jared Weiss; Ravit Geva; Chia-Chi Lin; Hyun Cheol Chung; Amy Meister; Marisa Dolled-Filhart; Kumudu Pathiraja; Jonathan D Cheng; Tanguy Y Seiwert
Journal: J Clin Oncol Date: 2016-09-30 Impact factor: 44.544

10. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.

Authors: Nicholas McGranahan; Andrew J S Furness; Rachel Rosenthal; Sofie Ramskov; Rikke Lyngaa; Sunil Kumar Saini; Mariam Jamal-Hanjani; Gareth A Wilson; Nicolai J Birkbak; Crispin T Hiley; Thomas B K Watkins; Seema Shafi; Nirupa Murugaesu; Richard Mitter; Ayse U Akarca; Joseph Linares; Teresa Marafioti; Jake Y Henry; Eliezer M Van Allen; Diana Miao; Bastian Schilling; Dirk Schadendorf; Levi A Garraway; Vladimir Makarov; Naiyer A Rizvi; Alexandra Snyder; Matthew D Hellmann; Taha Merghoub; Jedd D Wolchok; Sachet A Shukla; Catherine J Wu; Karl S Peggs; Timothy A Chan; Sine R Hadrup; Sergio A Quezada; Charles Swanton
Journal: Science Date: 2016-03-03 Impact factor: 47.728

6 in total

Review 1. Xeroderma pigmentosum: an updated review.

Authors: Alexander Kc Leung; Benjamin Barankin; Joseph M Lam; Kin Fon Leong; Kam Lun Hon
Journal: Drugs Context Date: 2022-04-25

Review 2. Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?

Authors: Anja Wessely; Theresa Steeb; Ulrike Leiter; Claus Garbe; Carola Berking; Markus Vincent Heppt
Journal: Int J Mol Sci Date: 2020-12-06 Impact factor: 5.923

3. Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review.

Authors: Marco Rubatto; Martina Merli; Gianluca Avallone; Andrea Agostini; Luca Mastorino; Virginia Caliendo; Amelia Barcellini; Viviana Vitolo; Francesca Valvo; Maria Teresa Fierro; Simone Ribero; Pietro Quaglino
Journal: Oncotarget Date: 2021-05-25